Review
The clinical spectrum of albinism in humans

https://doi.org/10.1016/1357-4310(96)81798-9Get rights and content

Abstract

Oculocutaneous albinism is characterized by a congenital reduction or absence of melanin pigment in the skin, hair and eyes. The reduction in the hair and skin results in a change in color but no change in the development of function of these tissues, while the absence of melanin pigment in the eye leads to abnormal development and function. Of particular interest are mutations that are associated with a slow accumulation of pigment in the hair and eyes over time, while retaining the ocular defects of albinism. Analysis of these mutations might provide the insight that we need to understand the interaction between the pigment system and the development of the optic system.

References (38)

  • C.J. Witkop et al.

    Autosomal recessive oculocutaneous albinism in man: evidence for genetic heterogeneity

    Am. J. Hum. Genet.

    (1970)
  • L.B. Giebel

    Tyrosinase gene mutations associated with type IA (‘yellow’) oculocutaneous albinism

    Am. J. Hum. Genet.

    (1991)
  • W.S. Oetting et al.

    Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene

    Hum. Mutat.

    (1993)
  • R.A. Spritz

    Molecular genetics of oculocutaneous albinism

    Hum. Mol. Genet.

    (1994)
  • W.S. Oetting et al.

    The molecular basis of oculocutaneous albinism

    J. Invest. Dermatol.

    (1994)
  • W.P.J. Gaykema

    3.2 Å structure of the copper-containing, oxygen-carrying protein Panulirus interruptus haemocyanin

    Nature

    (1984)
  • D.E. Wilcox

    Substrate analog binding to the couple binuclear copper active site in tyrosinase

    J. Am. Chem. Soc.

    (1985)
  • W.S. Oetting et al.

    Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism

    Pigment Cell Res.

    (1992)
  • A.N. Okoro

    Albinism in Nigeria

    Br. J. Dermatol.

    (1975)
  • Cited by (50)

    • Current and emerging treatments for albinism

      2021, Survey of Ophthalmology
      Citation Excerpt :

      The defect in OCA2 has been shown to cause tyrosinase to accumulate in the endoplasmic reticulum or Golgi apparatus and is eventually secreted from the cell, rather than reaching melanosomes.107,166 Phenotypically, OCA2 is milder than OCA1, but the spectrum of pigmentation is broad, ranging from almost no cutaneous pigmentation to virtually normal.128 Visual dysfunction is also less severe compared with OCA1.56

    • Computational analysis of deleterious SNPs of SLC45A2 involved in oculocutaneous albinism type 4

      2018, Gene Reports
      Citation Excerpt :

      Albinism is a type of inborn errors of metabolism characterized by a decrease in pigmentation due to deficiency of tyrosinase in the melanin biosynthesis pathway (Garrod, 1923). This group of congenital disorders is classified into two main types, namely (i) Ocular albinism (OA) an albinism disorder involving complete absence of pigmentation in the eyes and (ii) Oculocutaneous albinism (OCA), a disorder involving absence of pigmentation or presence of hypopigmentation in the skin, hair and eyes (Oetting et al., 1996). OCA is further categorized into seven sub-types, namely OCA1 (TYR), OCA2 (OCA2), OCA3 (TYRP1), OCA4 (SLC45A2), OCA5 (mapped to chr.4q24), OCA6 (SLC24A5) and OCA7 (C10orf11) (Montoliu et al., 2014) based on multiple heterogeneity and in each sub-type a different gene is found to be mutated.

    • Clinical Features, Types of Albinism, and Natural History

      2018, Albinism in Africa: Historical, Geographic, Medical, Genetic, and Psychosocial Aspects
    View all citing articles on Scopus
    View full text